Sab Biotherapeutics, Inc. · NASDAQ:SABS

Ra Capital Management, L.P. reported a 9.90% stake in Sab Biotherapeutics, Inc. (Schedule 13D/A)

Event Aug 6, 2026 · Filed Aug 10, 2026

Ra Capital Management, L.P. reported a 9.90% stake in Sab Biotherapeutics, Inc., 9,609,852 shares, with active intent on Aug 6, 2026. Filed Aug 10, 2026 (Schedule 13D/A).

Stake
9.90%
Shares
9,609,852
Intent
Active
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
RA Capital Management, L.P.9.90%9,609,852
Peter Kolchinsky9.90%9,609,852
Rajeev Shah9.90%9,609,852
RA Capital Healthcare Fund, L.P.9.90%9,609,852

Source

View original at SEC

Related